Daniel Brown > Latham & Watkins LLP > New York, United States > Lawyer Profile
Latham & Watkins LLP Offices

1271 Avenue of the Americas
NEW YORK
NY 10020
United States
- Firm Profile
- Go to...
Daniel Brown

Position
Daniel Brown, a seasoned first-chair patent trial lawyer, represents pharmaceutical and life sciences companies in patent litigation and other existential disputes, as well as advising on complex cross-disciplinary strategy.
Daniel leverages his chemical engineering background and extensive pharmaceutical IP litigation experience to help clients navigate matters involving patent protection, Food and Drug Administration (FDA) regulation, antitrust and competition, inter partes reexamination proceedings, trade secrets, business and licensing transactions and disputes, due diligence, and investigations. He guides clients on:
-
- Pharmaceutical and life sciences litigation, trials, and appeals
- Hatch-Waxman Act cases
- Complex matters involving simultaneous patent, antitrust, and FDA litigation
- Patent litigation parallel with Patent Office re-issue, reexamination, and interference proceedings
- Coordinated litigation proceedings in multiple countries, including strategizing with local counsel
He delivers strategy and counseling from a business-focused perspective, coordinating FDA, litigation, and commercial strategy. Daniel connects clients to resources across Latham’s integrated global platform to maximize value, particularly across the FDA Regulatory, Antitrust & Competition, and Government Contracts Practices.
Top Tier Firm Rankings
- Insurance > Advice to policyholders
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Cartel
- International trade and national security > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Finance > Commercial lending
- Intellectual property > Copyright
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Environment > Environment: litigation
- Environment > Environment: regulatory
- Environment > Environment: transactional
- Finance > Fintech
- Real estate > Land use/zoning
- Environment > Environment: regulatory
- Environment > Environment: regulatory
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Dispute resolution > Financial services litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Media, technology and telecoms > Media and entertainment: litigation
- Media, technology and telecoms > Media and entertainment: transactional
- Antitrust > Merger control
- Environment > Environment: regulatory
- Environment > Environment: regulatory
- Intellectual property > Patents: licensing
- Intellectual property > Patents: litigation (full coverage)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Finance > Project finance
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Energy > Renewable/alternative power
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Industry focus > Sport
- Finance > Structured finance: derivatives and structured products
- Media, technology and telecoms > Technology transactions
- Media, technology and telecoms > Telecoms and broadcast: regulatory
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
Firm Rankings
- M&A/corporate and commercial > Corporate governance
- International trade and national security > Customs, export controls and economic sanctions
- Energy > Energy regulation: electric power
- Energy > Energy regulation: oil and gas
- Dispute resolution > General commercial disputes
- Government > Government contracts
- Insurance > Insurance: non-contentious
- Dispute resolution > International litigation
- Investment fund formation and management > Private equity funds (including venture capital)
- Healthcare > Service providers
- Finance > Structured finance: securitization
- M&A/corporate and commercial > Venture capital and emerging companies
- Dispute resolution > Financial services litigation
- Healthcare > Health insurers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > International arbitration
- Intellectual property > Trademarks: litigation
- Finance > Financial services regulation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense
- M&A/corporate and commercial > Shareholder activism